FACE-IT - Feasibility and Economic Evaluation of Improved Child Deworming

Parasitic worm infections are still very common, particularly among children living in areas with limited access to safe drinking water and adequate sanitation. Additionally, this age group is at highest risk of morbidity associated with chronic worm infections. Current disease control efforts consist of mass distribution of a deworming drug to schoolchildren without prior diagnosis. However, standard interventions often do not cure a large proportion of the treated children, since common drugs show low cure rates against some parasitic worm species or are not suitable for administration to young children. This project aims at promoting innovation in child mass deworming in order to increase its effectiveness and accelerate the way towards elimination of soil-transmitted helminthiasis and schistosomiasis through implementation research studies in Uganda. Moreover, the consortium will assess the cost-effectiveness of new child-deworming treatments and develop delivery toolkits tailored to local settings. The project aims to contribute to the advancement of child worm infection management in low- and middle-income countries and support policy change at national and international levels.


Jennifer Keiser

Jennifer Keiser, Associate Professor, PhD
Head of Unit


Project Facts

Collaborating Institutions